<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>USP5 &#8211; openlabnotebooks.org</title>
	<atom:link href="https://thesgc.github.io/static-openlabnotebooks/category/project/usp5/feed/" rel="self" type="application/rss+xml" />
	<link>https://thesgc.github.io/static-openlabnotebooks/</link>
	<description>A growing team of groundbreaking scientists around the world are now sharing their lab notebooks online</description>
	<lastBuildDate>Tue, 12 Mar 2019 11:57:59 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=4.9.10</generator>

<image>
	<url>https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/01/cropped-lab-jar02-32x32.png</url>
	<title>USP5 &#8211; openlabnotebooks.org</title>
	<link>https://thesgc.github.io/static-openlabnotebooks/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>USP5 Zf-UBD Co-Crystal Structure with Compound XSR00035795a &#038; Testing Selectivity</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-co-crystal-structure-with-compound-xsr00035795a-testing-selectivity/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-co-crystal-structure-with-compound-xsr00035795a-testing-selectivity/#respond</comments>
		<pubDate>Fri, 01 Mar 2019 19:24:16 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2548</guid>
		<description><![CDATA[In a previous post, I tested hit analogues against USP5 Zf-UBD using a SPR assay. Compound AE-641/11456811, now aptly re-named XSR00035795a (an SGC global ID- since our database infrastructure is finally re-vamped), had a binding affinity of approximately 60 µM. The addition of a methyl group on the carboxylic chain of the compound increased potency <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-co-crystal-structure-with-compound-xsr00035795a-testing-selectivity/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>In a <a href="https://thesgc.github.io/static-openlabnotebooks/testing-hit-analogues-against-usp5-zf-ubd-with-spr-assay-1/">previous post</a>, I tested hit analogues against USP5 Zf-UBD using a SPR assay. Compound AE-641/11456811, now aptly re-named XSR00035795a (an SGC global ID- since our database infrastructure is finally re-vamped), had a binding affinity of approximately 60 µM. The addition of a methyl group on the carboxylic chain of the compound increased potency 3-fold!</p>
<p>You can find details of this experiment on <a href="https://zenodo.org/record/2581522#.XHmFHIhKjIU">Zenodo</a>. I crystallized the complex of USP5 Zf-UBD with XSR00035795a, and the structure was solved by Dr. Wolfram Tempel. The addition of the methyl group leads to increased hydrophobic interactions in the binding pocket with W209; the side chain of R221 also rotates out of the pocket (Figure 1).</p>
<p><img class="wp-image-2549 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301e-300x122.png" alt="" width="585" height="237" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301e-300x122.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301e-768x313.png 768w" sizes="(max-width: 585px) 100vw, 585px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. a) Superimposed USP5 structures of compound DAT194 (PDB: 6NFT; cyan) and compound XSR00035795a (magenta) b) Binding pocket of co-crystal structure of USP5 Zf-UBD and XSR00035795a</p>
<p>Next, I tested this compound against HDAC6 Zf-UBD to see if it confers selectivity against USP5 Zf-UBD using a SPR assay (Figure 2). Compound XSR00035795a (LE=0.36) was not selective for USP5 Zf-UBD. XSR00035795a and HDAC6 Zf-UBD has a K<sub>D</sub> of 15 ± 0.4 µM (n=2) whereas USP5 Zf-UBD has an average K<sub>D</sub> of 60 ± 8 µM (n=3).</p>
<p style="text-align: left;">a)                                                                                                        b)<img class="wp-image-2550 alignnone" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301f-300x75.png" alt="" width="648" height="162" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301f-300x75.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301f-768x193.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301f-1024x257.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301f.png 1372w" sizes="(max-width: 648px) 100vw, 648px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. Representative SPR binding curves and sensograms of compound XSR00035795a with a) HDAC6 Zf-UBD (K<sub>D</sub>= 15 ± 0.4 µM; n=2) and b) USP5 Zf-UBD (K<sub>D</sub>= 60 ± 8 µM; n=3)</p>
<p>When co-crystal structures of HDAC6 Zf-UBD and USP5 Zf-UBD are superimposed, binding of XSR00035795a to HDAC6 Zf-UBD makes sense. Figure 3 shows the binding pocket of HDAC6 Zf-UBD is able to accommodate the methyl group of compound XSR00035795a. Replacing a valine residue in the primary pocket of HDAC6 with an alanine in USP5 generates a small cavity that may be exploited by extending the aliphatic group on the carboxylic chain to confer selectivity towards USP5.</p>
<p><img class=" wp-image-2551 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301g-300x226.png" alt="" width="448" height="336" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301g-300x226.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301g-350x263.png 350w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/03/20190301g-250x188.png 250w" sizes="(max-width: 448px) 100vw, 448px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. Superimposed CPK representation of HDAC6 Zf-UBD (purple PDB: 6CE8) and USP5 Zf-UBD and compound XSR00035795a co-crystal structure (cyan)</p>
<p>Commercial compounds with extended aliphatic groups on the scaffold have been ordered but unfortunately due to vendor delays, I haven’t received them! Here’s hoping the compounds will arrive soon…</p>
<p>On another note, I will be doing a three month internship at the Montreal biotech, Molecular Forecaster Inc., as part of a NSERC-CREATE ChemNET grant. I will further explore computational chemistry approaches and structure-based drug design to design inhibitors against USP5 Zf-UBD and use the docking platform to dock compounds against available subfamily protein domain structures, as a predictive tool for selectivity. I’ll be heading to Montreal next week! Stay tuned for some neat computational simulations against USP5 Zf-UBD and the results of the extended aliphatic groups on the XSR00035795a scaffold.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-co-crystal-structure-with-compound-xsr00035795a-testing-selectivity/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Testing Hit Analogues against USP5 Zf-UBD with SPR Assay #1</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/testing-hit-analogues-against-usp5-zf-ubd-with-spr-assay-1/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/testing-hit-analogues-against-usp5-zf-ubd-with-spr-assay-1/#respond</comments>
		<pubDate>Thu, 24 Jan 2019 15:34:40 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2393</guid>
		<description><![CDATA[In a previous post, I described using hit expansion tools such as commercial substructure searches, docking, and free energy perturbation (FEP) simulations to explore the structure activity relationship (SAR) of the chemical series focused on the Zf-UBD of USP5. The first batch of commercially ordered compounds arrived just before the Christmas holidays. I decided to <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/testing-hit-analogues-against-usp5-zf-ubd-with-spr-assay-1/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>In a <a href="https://thesgc.github.io/static-openlabnotebooks/hit-expansion-using-substructure-search-free-energy-perturbation/">previous post</a>, I described using hit expansion tools such as commercial substructure searches, docking, and free energy perturbation (FEP) simulations to explore the structure activity relationship (SAR) of the chemical series focused on the Zf-UBD of USP5. The first batch of commercially ordered compounds arrived just before the Christmas holidays. I decided to tackle testing the chemical analogues in the New Year. I used a surface plasmon resonance (SPR) assay to determine binding affinities of commercially ordered analogues, designed from compounds hits listed in Table 1. You can see details on <a href="https://zenodo.org/record/2548710#.XEnZclxKjIU">Zenodo</a><strong>. </strong></p>
<p style="text-align: left;"><strong>Table 1</strong>. Compound Hits from which chemical analogues were designed</p>
<p><img class="wp-image-2394 alignleft" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124a-300x153.png" alt="" width="451" height="231" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124a-300x153.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124a.png 678w" sizes="(max-width: 451px) 100vw, 451px" /></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>Of the 19 analogues tested, compound AE-641/11456811, an analogue of DAT194 (K<sub>D</sub>= 215 µM; n=9) had a binding affinity of approximately 65 µM (n=6) and an excellent ligand efficiency of 0.36 (Figure 1). The addition of a methyl group increased potency 3-fold!</p>
<p><img class=" wp-image-2395 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190125b-300x83.png" alt="" width="473" height="131" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190125b-300x83.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190125b-768x212.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190125b-780x218.png 780w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190125b.png 788w" sizes="(max-width: 473px) 100vw, 473px" /></p>
<p style="text-align: center;">Figure 1. A) Compound DAT194 B) Compound AE-641/11456811</p>
<p>Compound DAT194 (PDB: 6NFT) and the docked pose of AE-641/11456811 are shown in Figure 2a. The addition of the methyl group leads to increased hydrophobic interactions in the binding pocket with W209. In Figure 2b, the docked pose of AE-641/11456811 shows the methyl group fits into a small groove in the pocket. Based on the docked pose, it may be possible to further extend the non-polar group into the pocket to increase the potency further. For this reason, compounds in Figure 3 were ordered as follow up compounds of AE-641/11456811.</p>
<p><img class="wp-image-2396 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124c-300x101.png" alt="" width="529" height="178" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124c-300x101.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124c-768x258.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124c.png 900w" sizes="(max-width: 529px) 100vw, 529px" /></p>
<p style="text-align: center;"><strong>Figure 2.</strong> A) Compound DAT194 (PDB: 6NFT) in magenta and docked pose of AE-641/11456811 (yellow) B) Binding pocket of USP5 Zf-UBD and docked pose AE-641/11456811 (yellow)</p>
<p><img class=" wp-image-2397 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124d-300x181.png" alt="" width="290" height="175" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124d-300x181.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/01/20190124d.png 708w" sizes="(max-width: 290px) 100vw, 290px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. Follow up compounds of AE-641/11456811</p>
<p>Analogues of DAT180 and DAT201 that were tested did not show a significant improvement in potency. So far, I’ve tested 19 of the 39 analogue compounds of DAT180, DAT194 and DAT201 that were selected in the hit expansion. Some compounds required custom synthesis and were not ordered, and others are still in transit. I will be testing the rest of the analogues once the next batch of compounds arrive, as well as testing follow up compounds of AE-641/11456811. I’ll also be setting up co-crystal trays of USP5 Zf-UBD and AE-641/11456811 for structure determination. Stay tuned!</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/testing-hit-analogues-against-usp5-zf-ubd-with-spr-assay-1/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>USP Zf-UBD Crystallography Pipeline Pt 2.</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline-pt-2/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline-pt-2/#respond</comments>
		<pubDate>Fri, 14 Dec 2018 22:28:00 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2266</guid>
		<description><![CDATA[In a previous post, I described the importance of solving the structure of other USPs that have a Zf-UBD for the rational design of selective compounds. The last post described the design, cloning, E.coli expression, growth and purification of some of the USP Zf-UBD constructs. As a continuation in my quest to try and crystallize <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline-pt-2/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>In a previous <a href="https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline/">post</a>, I described the importance of solving the structure of other USPs that have a Zf-UBD for the rational design of selective compounds. The last post described the design, cloning, <em>E.coli </em>expression, growth and purification of some of the USP Zf-UBD constructs. As a continuation in my quest to try and crystallize the other USP Zf-UBDs I’ve finished purifying and setting up crystallization screens of the ‘TOC013’ constructs in an attempt to crystallize these protein samples for subsequent structure determination by X-ray crystallography. You can see details on <a href="https://zenodo.org/record/2284636#.XBQt_lxKiUk"><strong>Zenodo</strong></a>.  I previously described getting crystals of USP33 that did not diffract and USP20 microcrystals that were too small to mount. I tried ‘seeding’ these initial crystal conditions in the hopes of getting larger crystals that diffract. Micro-seeding is the process of adding a dilute solution of m<span style="font-size: 1.5rem;">icro-crystals to a crystallizing solution to nucleate more crystals. This helps in controlling size and reproducibility.</span></p>
<p>So far, I have not had any luck with seeding but it may just be a matter of time- some proteins take longer to crystallize than others. I’ll have to keep an eye on my plates. Hopefully I’ll have some luck in the New Year and come back to crystals after the holidays! The USP Zf-UBD crystallization pipeline to date is summarized in Table 1.</p>
<p style="text-align: center;"><strong>Table 1</strong>. Summary of USP Zf-UBD Crystallization</p>
<table style="height: 2843px;" width="694">
<tbody>
<tr>
<td style="width: 73.9205px;"><strong>Clone </strong></td>
<td style="width: 41.1932px;"><strong>Target</strong></td>
<td style="width: 26.6477px;"><strong>AA </strong></td>
<td style="width: 43.0114px;"><strong>Vector</strong></td>
<td style="width: 37.5568px;"><strong>Media</strong></td>
<td style="width: 49.375px;"><strong>Amount Grown (L)</strong></td>
<td style="width: 72.1023px;"><strong>Purification Yield (mg) </strong></td>
<td style="width: 44.8295px;"><strong>Crystal Plate Setup (Y/N) </strong></td>
<td style="width: 84.8295px;"><strong>Crystals? (Y/N) </strong></td>
<td style="width: 65.7386px;"><strong>Diffraction (Y/N)</strong></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013E09</td>
<td style="width: 41.1932px;">USP44</td>
<td style="width: 26.6477px;">27-110</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">12</td>
<td style="width: 72.1023px;">No/low expression</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013F02</td>
<td style="width: 41.1932px;">USP49</td>
<td style="width: 26.6477px;">15-105</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">12</td>
<td style="width: 72.1023px;">0.25 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013D10</td>
<td style="width: 41.1932px;">USP33</td>
<td style="width: 26.6477px;">37-124</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">15.7 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">Y</p>
<p>-seeding:100 nL of 1:1000 and 1:10000 SM of 1 µL drops of RWD01, RWE01, SGCF03 small microcrystals (SM concentration too high?)</td>
<td style="width: 65.7386px;">N</td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013D11</td>
<td style="width: 41.1932px;">USP33</td>
<td style="width: 26.6477px;">38-124</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">0.35 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013E02</td>
<td style="width: 41.1932px;">USP39</td>
<td style="width: 26.6477px;">97-197</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">1.6 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013E05</td>
<td style="width: 41.1932px;">USP39</td>
<td style="width: 26.6477px;">97-205</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">1.1 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013C02</td>
<td style="width: 41.1932px;">USP13</td>
<td style="width: 26.6477px;">188-292</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">Insoluble</td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013C03</td>
<td style="width: 41.1932px;">USP13</td>
<td style="width: 26.6477px;">208-292</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">Insoluble</td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013C04</td>
<td style="width: 41.1932px;">USP13</td>
<td style="width: 26.6477px;">208-308</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">2.4 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013B11</td>
<td style="width: 41.1932px;">USP03</td>
<td style="width: 26.6477px;">10-152</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">2 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013C08</td>
<td style="width: 41.1932px;">USP16</td>
<td style="width: 26.6477px;">26-146</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">0.7 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013C09</td>
<td style="width: 41.1932px;">USP16</td>
<td style="width: 26.6477px;">32-146</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">0.8 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013C11</td>
<td style="width: 41.1932px;">USP20</td>
<td style="width: 26.6477px;">1-100</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">4.8 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013D03</td>
<td style="width: 41.1932px;">USP20</td>
<td style="width: 26.6477px;">1-110</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">13.2 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">Y: small microcrystals SGCC08</p>
<p>&nbsp;</p>
<p>optimizing:</p>
<p>1) different protein concentrations (1, 2, 3, 4 mg/mL); no crystals</p>
<p>2) seeding with SGCC08; no crystals</p>
<p>&nbsp;</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013D04</td>
<td style="width: 41.1932px;">USP20</td>
<td style="width: 26.6477px;">8-110</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">7.2 mg</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013-D07</td>
<td style="width: 41.1932px;">USP22</td>
<td style="width: 26.6477px;">43-142</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">No/low expression</td>
<td style="width: 44.8295px;">N</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">TOC013D08</td>
<td style="width: 41.1932px;">USP22</td>
<td style="width: 26.6477px;">49-142</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">M9</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">No/low expression</td>
<td style="width: 44.8295px;">Y</td>
<td style="width: 84.8295px;">N</td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;"></td>
<td style="width: 41.1932px;"></td>
<td style="width: 26.6477px;"></td>
<td style="width: 43.0114px;"></td>
<td style="width: 37.5568px;"></td>
<td style="width: 49.375px;"></td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 708.466px;" colspan="10">Constructs previously available in SGC database that have high expression:</td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC093D04</td>
<td style="width: 41.1932px;">USP13</td>
<td style="width: 26.6477px;">183-307</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;">26.3 mg</td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC093D05</td>
<td style="width: 41.1932px;">USP13</td>
<td style="width: 26.6477px;">187-301</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC024F07</td>
<td style="width: 41.1932px;">USP16</td>
<td style="width: 26.6477px;">34-185</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC024F09</td>
<td style="width: 41.1932px;">USP16</td>
<td style="width: 26.6477px;">16-185</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC024F10</td>
<td style="width: 41.1932px;">USP16</td>
<td style="width: 26.6477px;">8-185</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC036B06</td>
<td style="width: 41.1932px;">USP20</td>
<td style="width: 26.6477px;">1-141</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC042G05</td>
<td style="width: 41.1932px;">USP33</td>
<td style="width: 26.6477px;">7-139</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC042G06</td>
<td style="width: 41.1932px;">USP33</td>
<td style="width: 26.6477px;">7-167</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC042G07</td>
<td style="width: 41.1932px;">USP33</td>
<td style="width: 26.6477px;">7-183</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC168E10</td>
<td style="width: 41.1932px;">USP44</td>
<td style="width: 26.6477px;">1-167</td>
<td style="width: 43.0114px;">pET28-MHL</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC231F11</td>
<td style="width: 41.1932px;">USP51</td>
<td style="width: 26.6477px;">160-350</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
<tr>
<td style="width: 73.9205px;">SDC231-G03</td>
<td style="width: 41.1932px;">USP51</td>
<td style="width: 26.6477px;">176-350</td>
<td style="width: 43.0114px;">pET28-LIC</td>
<td style="width: 37.5568px;">TB</td>
<td style="width: 49.375px;">6</td>
<td style="width: 72.1023px;"></td>
<td style="width: 44.8295px;"></td>
<td style="width: 84.8295px;"></td>
<td style="width: 65.7386px;"></td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline-pt-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Development of a Mass Spectrometry USP5 Catalytic Activity Assay</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/development-of-a-mass-spectrometry-usp5-catalytic-activity-assay/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/development-of-a-mass-spectrometry-usp5-catalytic-activity-assay/#respond</comments>
		<pubDate>Fri, 23 Nov 2018 17:04:50 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2182</guid>
		<description><![CDATA[Now that I’ve got my biophysical screening assays developed (19F NMR, SPR), as well as my hit expansion campaign started for small molecule inhibitors against the USP5 Zf-UBD, I need to be able to test if these small molecule inhibitors will antagonize the catalytic activity of USP5. It has been speculated in literature that the <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/development-of-a-mass-spectrometry-usp5-catalytic-activity-assay/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Now that I’ve got my biophysical screening assays developed (<a href="https://thesgc.github.io/static-openlabnotebooks/compounds-of-interest-identified-by-screening-a-focused-library-against-usp5-zf-ubd-with-a-19f-nmr-assay/">19F NMR</a>, <a href="https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-with-a-surface-plasmon-resonance-assay/">SPR</a>), as well as my<a href="https://thesgc.github.io/static-openlabnotebooks/hit-expansion-using-substructure-search-free-energy-perturbation/"> hit expansion campaign</a> started for small molecule inhibitors against the USP5 Zf-UBD, I need to be able to test if these small molecule inhibitors will antagonize the catalytic activity of USP5.</p>
<p>It has been speculated in literature that the Zf-UBD is responsible for substrate recruitment, substrate positioning for proper conformation for cleavage, and that binding of ubiquitin at the Zf-UBD allosterically activates catalytic cleavage; however, the exact function of the Zf-UBD is still unclear. Perhaps, the Zf-UBD is more important for the cleavage of some substrates than others. For this reason, I need an assay that will work with diverse substrates to elucidate the function of the Zf-UBD in regards to catalytic activity.</p>
<p>I was able to express and purify full length USP5 and SGC’s Dr. Suzanne Ackloo developed and optimized a mass spectrometry (MS) assay to detect polyubiquitin cleavage. You can see full experimental details on <a href="https://zenodo.org/record/1495189#.W_gyzuhKjIU">Zenodo</a>. Mass spectrometry is an analytical tool used to sort ions on the basis of their mass-charge ratio; this allows for the measurements of masses within a sample. Before the reaction begins I am able to see a clear intensity of the substrate, a tetra-ubiquitin species (Ub4K63). After the addition of USP5, over time the tetra-ubiquitin (Ub4) is cleaved into tri, di and mono-ubiquitin (Ub3, Ub2, Ub1) (<strong>Figure 1</strong>).</p>
<p>&nbsp;</p>
<p><img class="wp-image-2183 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181123a-300x171.png" alt="" width="567" height="323" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181123a-300x171.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181123a-768x437.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181123a.png 927w" sizes="(max-width: 567px) 100vw, 567px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. Mass spectra of a) Substrate Ub4K63 b) 20 ng USP5 reaction at 1 hour</p>
<p>Next, I’ll be testing some of the small molecule inhibitors of the zinc-finger ubiquitin binding domain (Zf-UBD) in the mass spectrometry assay to determine if the small molecules can antagonize the catalytic activity of USP5.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/development-of-a-mass-spectrometry-usp5-catalytic-activity-assay/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hit Expansion using Substructure Search, Virtual Screening &#038; Free Energy Perturbation</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/hit-expansion-using-substructure-search-free-energy-perturbation/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/hit-expansion-using-substructure-search-free-energy-perturbation/#respond</comments>
		<pubDate>Fri, 16 Nov 2018 18:09:30 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2155</guid>
		<description><![CDATA[Molecular dynamic simulations are a powerful tool for modeling biomolecular systems such as ligand binding to proteins. In a previous post I was able to get co-crystal structures of ligands which bind to the USP5 zinc finger ubiquitin binding domain (Zf-UBD). In order to explore the structure activity relationship (SAR) of the chemical series, so <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/hit-expansion-using-substructure-search-free-energy-perturbation/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Molecular dynamic simulations are a powerful tool for modeling biomolecular systems such as ligand binding to proteins. In a previous <a href="https://thesgc.github.io/static-openlabnotebooks/co-crystal-structures-of-usp5-zf-ubd-and-weak-binding-compounds/">post</a> I was able to get co-crystal structures of ligands which bind to the USP5 zinc finger ubiquitin binding domain (Zf-UBD). In order to explore the structure activity relationship (SAR) of the chemical series, so I can rationally design more potent ligands, I used MolPort and Emoleules to find chemically related, commercially available molecules, and then used free energy perturbation (FEP) to prioritize compound ordering. You can see full experimental details on <a href="https://zenodo.org/record/1490065#.W-8GzOhKjIU">Zenodo</a><strong>. </strong>Free energy perturbation (FEP) is a computational chemistry tool that allows for the thermodynamic calculation of relative binding free energy<sup>1</sup>. The binding free energy difference can be calculated by the difference of the free energy of transforming ligand 1 to ligand 2 in the solvent and in complex with a receptor (<strong>Figure 1</strong>)<sup>1</sup>.</p>
<p><img class="size-medium wp-image-2156 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116a-297x300.png" alt="" width="297" height="300" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116a-297x300.png 297w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116a.png 373w" sizes="(max-width: 297px) 100vw, 297px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. Thermodynamic pathway of calculating the free energy difference<sup>1</sup></p>
<p>As an example, for DAT180, I did a substructure search using constraints on the aromatic rings as well as the carboxyl group of the compound which was shown to be an important interaction in the co-crystal structure. I got a few hundred hits which I docked to the Zf-UBD while imposing H-bonding constraints between the R221/Y261, and the carboxylate of the compound, important interactions in the binding pocket (<strong>Figure 2</strong>).</p>
<p><img class="size-medium wp-image-2157 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116b-300x194.png" alt="" width="300" height="194" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116b-300x194.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116b.png 517w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. Co-crystal structure of USP5 Zf-UBD and DAT180 (PDB: 6DXT)</p>
<p>After docking, 30 compounds were selected on the basis of visual inspection &amp; chemistry intuition, molecular weight, and docking scores. I used FEP as a tool to estimate the free energy difference of analogues of the ligands from the co-crystal structures that bind with micromolar affinity, as shown by <a href="https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-with-a-surface-plasmon-resonance-assay/">SPR</a>, for a final selection of 17 compounds (<strong>Figure 3</strong>).</p>
<p><img class=" wp-image-2158 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116c-300x96.png" alt="" width="438" height="140" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116c-300x96.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116c-768x246.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/11/20181116c.png 917w" sizes="(max-width: 438px) 100vw, 438px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. Hit expansion summary of DAT180</p>
<p>I’ve ordered the selected compounds from the substructure searches/FEP. Hopefully, the next batch of compounds I test experimentally will have increased potency. More on this soon!</p>
<p>&nbsp;</p>
<p><sup>1</sup><em>Acc. Chem. Res.</em>, <strong>2017</strong>, <em>50</em> (7), pp 1625–1632</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/hit-expansion-using-substructure-search-free-energy-perturbation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>USP Zf-UBD Crystallography Pipeline</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline/#respond</comments>
		<pubDate>Mon, 29 Oct 2018 14:18:47 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=2064</guid>
		<description><![CDATA[X-ray crystallography is a tool used for the structural determination of proteins and biological molecules. My specific project focuses on the zinc finger ubiquitin binding domain (Zf-UBD) of USP5; however, USP5 is just one of many USPs that contain a Zf-UBD. Table 1 shows a list of the USP Zf-UBDs and their available structures in <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>X-ray crystallography is a tool used for the structural determination of proteins and biological molecules. My specific project focuses on the zinc finger ubiquitin binding domain (Zf-UBD) of USP5; however, USP5 is just one of many USPs that contain a Zf-UBD. <strong>Table 1</strong> shows a list of the USP Zf-UBDs and their available structures in the protein data bank (PDB).  In addition, the protein BRAP also has a Zf-UBD. My recently identified USP5 inhibitors are far from being optimized, but my goal is to find compounds that are potent and selective for USP5 and that can be used by cell-biologists. I will need to test them against other Zf-UBD’s to determine their specificity. Crystal structures of other Zf-UBD’s will be useful to rational design selective compounds.</p>
<p><strong>Table 1</strong>. USP Zf-UBDs &amp; Available PDB Structures</p>
<table style="height: 869px; width: 235px;" width="334">
<tbody>
<tr>
<td style="width: 105.527px;"><strong>Target Zf-UBD </strong></td>
<td style="width: 91.7773px;"><strong>PDB ID </strong></td>
</tr>
<tr>
<td style="width: 105.527px;">USP3</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
<tr>
<td style="width: 105.527px;">USP5</td>
<td style="width: 91.7773px;">2G43 (X-ray)</p>
<p>2G45 (X-ray)</p>
<p>3IHP (X-ray)</p>
<p>6DXH (X-ray)</p>
<p>6DXT (X-ray)</td>
</tr>
<tr>
<td style="width: 105.527px;">USP13</td>
<td style="width: 91.7773px;">2L80 (NMR)</td>
</tr>
<tr>
<td style="width: 105.527px;">USP16</td>
<td style="width: 91.7773px;">2I50 (NMR)</td>
</tr>
<tr>
<td style="width: 105.527px;">USP20</td>
<td style="width: 91.7773px;">5Z4I (NMR)</td>
</tr>
<tr>
<td style="width: 105.527px;">USP22</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
<tr>
<td style="width: 105.527px;">USP33</td>
<td style="width: 91.7773px;">2UZG (NMR)</td>
</tr>
<tr>
<td style="width: 105.527px;">USP39</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
<tr>
<td style="width: 105.527px;">USP44</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
<tr>
<td style="width: 105.527px;">USP45</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
<tr>
<td style="width: 105.527px;">USP49</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
<tr>
<td style="width: 105.527px;">USP51</td>
<td style="width: 91.7773px;">N/A</td>
</tr>
</tbody>
</table>
<p>I designed constructs of the different USP Zf-UBDs through analysis of the available structures and by using secondary structure prediction tools. Peter Loppnau, SGC’s cloning expert ordered primers and cloned my constructs into expression vector pET28-MHL to allow expression and purification from bacterial production. Linda Lin, another talented colleague, then did a test expression experiment using small-scale cultures to see if there was expression of the constructs. I designed 69 constructs of USP Zf-UBDs, and chose 17 that expressed well in the TestX and 12 available constructs already in the SGC database that have high expression. Next, I did large scale growth in bacteria and am now working my way through purifying them. Once proteins are pure, I set up crystal trays using our in-house screens. So far, I have identified some crystals for USP20 and USP33 Zf-UBD but they either don’t diffract or need more optimizing (<strong>Table 2</strong>). You can see full experimental details on<a href="https://zenodo.org/record/1473615#.W9cVW2hKjIU"> Zenodo</a>.</p>
<p><strong>Table 2</strong>. Summary of USP Zf-UBD Crystallization Pipeline To Date</p>
<table>
<tbody>
<tr>
<td style="width: 74px;"><strong>Clone </strong></td>
<td style="width: 46px;"><strong>Target</strong></td>
<td style="width: 50px;"><strong>AA </strong></td>
<td style="width: 79px;"><strong>Vector</strong></td>
<td style="width: 37px;"><strong>Media</strong></td>
<td style="width: 61px;"><strong>Amount Grown (L)</strong></td>
<td style="width: 82px;"><strong>Purification Yield (mg) </strong></td>
<td style="width: 56px;"><strong>Crystal Plate Setup (Y/N) </strong></td>
<td style="width: 70px;"><strong>Crystals? (Y/N) </strong></td>
<td style="width: 77px;"><strong>Diffraction (Y/N)</strong></td>
</tr>
<tr>
<td style="width: 74px;">TOC013E09</td>
<td style="width: 46px;">USP44</td>
<td style="width: 50px;">27-110</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">12</td>
<td style="width: 82px;">No/low expression</td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013F02</td>
<td style="width: 46px;">USP49</td>
<td style="width: 50px;">15-105</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">12</td>
<td style="width: 82px;">0.25 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;">N</td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013D10</td>
<td style="width: 46px;">USP33</td>
<td style="width: 50px;">37-124</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">15.7 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;">Y</td>
<td style="width: 77px;">N</td>
</tr>
<tr>
<td style="width: 74px;">TOC013D11</td>
<td style="width: 46px;">USP33</td>
<td style="width: 50px;">38-124</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">0.35 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;">N</td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013E02</td>
<td style="width: 46px;">USP39</td>
<td style="width: 50px;">97-197</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">1.6 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013E05</td>
<td style="width: 46px;">USP39</td>
<td style="width: 50px;">97-205</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013C02</td>
<td style="width: 46px;">USP13</td>
<td style="width: 50px;">188-292</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">Insoluble</td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013C03</td>
<td style="width: 46px;">USP13</td>
<td style="width: 50px;">208-292</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">Insoluble</td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013C04</td>
<td style="width: 46px;">USP13</td>
<td style="width: 50px;">208-308</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013B11</td>
<td style="width: 46px;">USP03</td>
<td style="width: 50px;">10-152</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013C08</td>
<td style="width: 46px;">USP16</td>
<td style="width: 50px;">26-146</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">0.7 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;">N</td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013C09</td>
<td style="width: 46px;">USP16</td>
<td style="width: 50px;">32-146</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013C11</td>
<td style="width: 46px;">USP20</td>
<td style="width: 50px;">1-100</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">4.8 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;">N</td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013D03</td>
<td style="width: 46px;">USP20</td>
<td style="width: 50px;">1-110</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">13.2 mg</td>
<td style="width: 56px;">Y</td>
<td style="width: 70px;">Y: optimizing</td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013D04</td>
<td style="width: 46px;">USP20</td>
<td style="width: 50px;">8-110</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013-D07</td>
<td style="width: 46px;">USP22</td>
<td style="width: 50px;">43-142</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;">No/low expression</td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">TOC013D08</td>
<td style="width: 46px;">USP22</td>
<td style="width: 50px;">49-142</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">M9</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;"></td>
<td style="width: 46px;"></td>
<td style="width: 50px;"></td>
<td style="width: 79px;"></td>
<td style="width: 37px;"></td>
<td style="width: 61px;"></td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 803px;" colspan="10">Constructs previously available in SGC database that have high expression:</td>
</tr>
<tr>
<td style="width: 74px;">SDC093D04</td>
<td style="width: 46px;">USP13</td>
<td style="width: 50px;">183-307</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC093D05</td>
<td style="width: 46px;">USP13</td>
<td style="width: 50px;">187-301</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC024F07</td>
<td style="width: 46px;">USP16</td>
<td style="width: 50px;">34-185</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC024F09</td>
<td style="width: 46px;">USP16</td>
<td style="width: 50px;">16-185</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC024F10</td>
<td style="width: 46px;">USP16</td>
<td style="width: 50px;">8-185</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;"></td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC036B06</td>
<td style="width: 46px;">USP20</td>
<td style="width: 50px;">1-141</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC042G05</td>
<td style="width: 46px;">USP33</td>
<td style="width: 50px;">7-139</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC042G06</td>
<td style="width: 46px;">USP33</td>
<td style="width: 50px;">7-167</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC042G07</td>
<td style="width: 46px;">USP33</td>
<td style="width: 50px;">7-183</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;"></td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC168E10</td>
<td style="width: 46px;">USP44</td>
<td style="width: 50px;">1-167</td>
<td style="width: 79px;">pET28-MHL</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;"></td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC231F11</td>
<td style="width: 46px;">USP51</td>
<td style="width: 50px;">160-350</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;"></td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
<tr>
<td style="width: 74px;">SDC231-G03</td>
<td style="width: 46px;">USP51</td>
<td style="width: 50px;">176-350</td>
<td style="width: 79px;">pET28-LIC</td>
<td style="width: 37px;">TB</td>
<td style="width: 61px;">6</td>
<td style="width: 82px;"></td>
<td style="width: 56px;"></td>
<td style="width: 70px;"></td>
<td style="width: 77px;"></td>
</tr>
</tbody>
</table>
<p>I still have some more constructs to grow and purify and hopefully I’ll be able to crystallize and solve some novel USP Zf-UBDs. More on this later!</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/usp-zf-ubd-crystallography-pipeline/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Screening Compounds of Interest against USP5 Zf-UBD by SPR #2</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-by-spr-2/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-by-spr-2/#respond</comments>
		<pubDate>Thu, 04 Oct 2018 15:11:41 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=1962</guid>
		<description><![CDATA[I used a surface plasmon resonance assay to determine the binding affinities of hit compounds that were identified in 19F NMR spectroscopy screens against the zinc finger ubiquitin binding domain of USP5. To see how these assays work, check out some of my previous posts! You can see details of the SPR experiment on Zenodo. <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-by-spr-2/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>I used a surface plasmon resonance assay to determine the binding affinities of hit compounds that were identified in <sup>19</sup>F NMR spectroscopy screens against the zinc finger ubiquitin binding domain of USP5. To see how these assays work, check out some of my <a href="https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-with-a-surface-plasmon-resonance-assay/">previous posts</a>! You can see details of the SPR experiment on <a href="https://zenodo.org/record/1445571#.W7YsIWhKjIU">Zenodo</a><strong>.</strong></p>
<p>Compound UBXML78 had the best binding affinity, with a K<sub>D</sub> of approximately 59 µM and a ligand efficiency LE=0.24 (Figure 1). DAT76 (K<sub>D</sub>  ̴ 109 µM) had the best ligand efficiency (LR=0.29) (Figure 2). These compounds are rather weak but together with my <a href="https://thesgc.github.io/static-openlabnotebooks/co-crystal-structures-of-usp5-zf-ubd-and-weak-binding-compounds/">previous crystal structures</a>, still provide a solid starting point for a hit optimization campaign.</p>
<p><img class=" wp-image-1963 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004a-300x110.png" alt="" width="420" height="154" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004a-300x110.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004a-768x281.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004a.png 893w" sizes="(max-width: 420px) 100vw, 420px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. Representative binding curve of UBXML78 and USP5 Zf-UBD</p>
<p><img class="wp-image-1964 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004b-e1538665829598-300x105.png" alt="" width="434" height="152" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004b-e1538665829598-300x105.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004b-e1538665829598-768x268.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/10/20181004b-e1538665829598.png 924w" sizes="(max-width: 434px) 100vw, 434px" /></p>
<p style="text-align: center;"><strong>Figure 2.</strong> Representative binding curve of DAT76 and USP5 Zf-UBD</p>
<p>Now that I’ve tested all the hit compounds from the <sup>19</sup>F NMR screens using SPR, I wanted to see if I could correlate the <sup>19</sup>F NMR assay results with the SPR binding affinity measurements. I find that a chemical shift greater than 1 ppm in the <sup>19</sup>F NMR assay results in binding affinities less than 400 µM. I can use this cut-off to select compounds for SPR based on the NMR screen. This will limit testing of very weak compounds by SPR.</p>
<p>Next, I’ll be doing hit expansions of a few of the compounds of interest where I will run substructure searches and docking simulations to select commercially available compounds for the next set of screening. This will hopefully increase my understanding of the structure activity relationship (SAR) of the chemical series, which in turn will inform the rational design of more potent USP5 Zf-UBD ligands. Stay tuned!</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-by-spr-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Developing a Tryptophan Fluorescence Assay for Screening Ligands against USP5 Zf-UBD</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/developing-a-tryptophan-fluorescence-assay-for-screening-ligands-against-usp5-zf-ubd/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/developing-a-tryptophan-fluorescence-assay-for-screening-ligands-against-usp5-zf-ubd/#respond</comments>
		<pubDate>Fri, 21 Sep 2018 13:31:12 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=1883</guid>
		<description><![CDATA[For those following the USP5 project on my open notebook, you will recognize that assay development has been quite a challenge for screening ligands against USP5 zinc finger ubiquitin binding domain (Zf-UBD). In the past, I was unsuccessful in developing a differential scanning fluorimetry, and fluorescence polarization screening assay. I then tried 19F NMR spectroscopy screening, <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/developing-a-tryptophan-fluorescence-assay-for-screening-ligands-against-usp5-zf-ubd/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>For those following the USP5 project on my open notebook, you will recognize that assay development has been quite a challenge for screening ligands against USP5 zinc finger ubiquitin binding domain (Zf-UBD). In the past, I was unsuccessful in developing a <a href="https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-differential-scanning-fluorimetry-assay-development-3/">differential scanning fluorimetry</a>, and <a href="https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-fluorescence-polarization-displacement-assay-3/">fluorescence polarization</a> screening assay. I then tried <a href="https://thesgc.github.io/static-openlabnotebooks/compounds-of-interest-identified-by-screening-a-focused-library-against-usp5-zf-ubd-with-a-19f-nmr-assay/">19F NMR spectroscopy</a> screening, where ligand binding could be detected by structural perturbations in the resonance of a fluorinated tryptophan at the binding pocket. This assay works well, but so far, it has been more of qualitative than quantitative assay. I also used a <a href="https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-with-a-surface-plasmon-resonance-assay/">surface plasmon resonance assay</a> (SPR) to quantify and validate the binding of small molecule compounds to the protein domain of interest. Although I am able to measure binding constants with the SPR assay, it would be good to have a secondary assay that validates binding measurements. Also, SPR chips can be quite expensive so having a cheaper, higher-throughput assay would also be beneficial.</p>
<p>The medium-throughput <sup>19</sup>F-NMR assay gave rise to the idea of exploiting the intrinsic fluorescence of aromatic amino acids of USP5 Zf-UBD for a quantitative screening assay. The three amino acids that are responsible for the intrinsic fluorescence of proteins are try<span style="font-size: 1.5rem;">ptophan, tyrosine and phenylalanine (Figure 1).</span></p>
<p><img class="wp-image-1884 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921a-300x190.png" alt="" width="224" height="142" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921a-300x190.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921a.png 507w" sizes="(max-width: 224px) 100vw, 224px" /></p>
<p style="text-align: center;"><strong>Figure </strong><strong style="font-size: 1.5rem;">1</strong><span style="font-size: 1.5rem;">. Chemical structure of aromatic amino acids</span></p>
<p>Aromatic amino acids have characteristic absorption and emission wavelengths, of which tryptophan has higher fluorescence than tyrosine or phenylalanine residu<span style="font-size: 1.5rem;">es in a protein. There are 2 tyrosines and one tryptophan in the USP5 Zf-UBD pocket (Figure 2): theoretically, if a ligand is binding, we should see a change in the measured UV fluorescence intensity. Using USP5</span><sup>171-290</sup><span style="font-size: 1.5rem;">, I attempted to develop a tryptophan fluorescence assay to detect ligand binding. You can find experimental details on </span><a style="font-size: 1.5rem;" href="https://zenodo.org/record/1424041#.W6Tw6mhKjIU">Zenodo</a><strong style="font-size: 1.5rem;">. </strong></p>
<p><img class="wp-image-1885 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921b-300x158.png" alt="" width="391" height="206" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921b-300x158.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921b.png 672w" sizes="(max-width: 391px) 100vw, 391px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. Aromatic amino acids in binding pocket of USP5<sup>171-290</sup> with compound DAT180 (PDB: <a href="https://www.rcsb.org/structure/6dxt">6DXT</a>)</p>
<p>As expected, as the concentration of USP5 Zf-UB<span style="font-size: 1.5rem;">D increases, the fluorescence intensity increases linearly (Figure 3). In other words, as the number of aromatic amino acids increases, the measured fluorescence intensity also increases.</span></p>
<p><img class="wp-image-1886 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921c-300x97.png" alt="" width="390" height="126" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921c-300x97.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921c.png 723w" sizes="(max-width: 390px) 100vw, 390px" /></p>
<p style="text-align: center;"><strong>Figure 3.</strong> USP5 Zf-UBD fluorescence intensity measurem<span style="font-size: 1.5rem;">ents</span></p>
<p>Next, I tested compounds I had previously identified and co-crystallized in the USP5 Zf-UBD pocket, and others that bind to USP5 Zf-UBD according to the <sup>19</sup>F NMR assay. Compound titrations were done in the presence and absence of USP5 Zf-UBD. Compound titrations in buffer only were used for blank subtraction to eliminate the fluorescence of the compou<span style="font-size: 1.5rem;">nds from measured fluorescence of the protein + compound. Compound titrations with N-acetyl L-tryptophanamide (NATA) (Sigma Aldrich), a tryptophan analog was used as a control for the inner filter effect (IFE) (Figure 5). </span></p>
<p><img class="wp-image-1887 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921d-300x193.png" alt="" width="162" height="104" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921d-300x193.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921d.png 575w" sizes="(max-width: 162px) 100vw, 162px" /></p>
<p style="text-align: center;"><strong>Figure 4</strong>. Structure of N-acetyl L-tryptophanamide (NATA)</p>
<p>The IFE is when the compound and protein both <span style="font-size: 1.5rem;">absorb at the excitation wavelength and the absorbance of the compound decreases emission of the protein. Theoretically, no change in fluorescence should be observed with compound titrations with NATA as the compounds are not expected to bind NATA. If a change in fluorescence is observed, this can be attributed to the IFE and corrected for using a correction factor.</span></p>
<p>The ubiquitin peptide, LRLRGG were used as positive<span style="font-size: 1.5rem;"> control for USP5 Zf-UBD. Although there is a slight increase in fluorescence as the concentration of the ubiquitin peptide increases, binding affinity could not be measured (Figure 4a). This is discouraging because if I can’t measure the binding affinity of my positive control, it will be difficult to assess the accuracy of measured binding affinities of other ligands. Interestingly, while the ubiquitin peptide showed an increase in fluorescence, all the compounds showed a decrease in fluorescence as the concentration of the compounds increased (Figure 4b). I am not sure why there is difference in the change in the fluorescence of the peptides versus the compounds, as both the peptide and the compounds showed perturbations of the tryptophan in the binding pocket with the </span><sup>19</sup><span style="font-size: 1.5rem;">F NMR assay. Perhaps, the way in which the peptide binds to the binding pocket changes the environment of the hydrophobic amino acids in a different manner than when the compounds bind to the Zf-UBD.</span></p>
<p><img class=" wp-image-1888 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921e-269x300.png" alt="" width="202" height="225" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921e-269x300.png 269w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921e.png 352w" sizes="(max-width: 202px) 100vw, 202px" /></p>
<p style="text-align: center;"><strong>Figure 5</strong>. 1:2.5 12 pt dilution series of a) LRLRGG and b)<span style="font-size: 1.5rem;"> DAT180 with 10 µM USP5</span><sup>171-290</sup></p>
<p>The negative controls DAT199 showed no binding to USP5 Zf-UBD (Figure 6).</p>
<p><img class=" wp-image-1889 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921f-300x162.png" alt="" width="233" height="126" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921f-300x162.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180921f.png 340w" sizes="(max-width: 233px) 100vw, 233px" /></p>
<p style="text-align: center;"><strong>Figure 6</strong>. 1:2.5 12 pt dilution series of DAT199 with 10 µM USP5<sup>171-290</sup></p>
<p>It looks like the tryptophan fluorescence assay can be used to detect ligand binding; however, it is difficult to conclude that the binding affinities of the ligands are accurate due the inability to measure the ubiquitin peptide as a positive control and the number of questions that have arisen. <strong>Anyone with expertise on this assay, could you please advise?</strong></p>
<p>1) Why is there a difference in the change of fluorescence with ubiquitin peptides vs. small molecule compounds?</p>
<p>2) Was the IFE correction method used the right mathematical model for this assay?</p>
<p>3) Are the binding affinities measured for the small m<span style="font-size: 1.5rem;">olecule compounds accurate, especially for those compounds that display the IFE?</span></p>
<p>As of right now, it doesn’t seem like I’ll be using this assay to screen compounds as I am uncertain how to interpret the data. In the future, I will be using a surface plasmon resonance (SPR) to measure the binding affinities of all these compounds. It will be interesting to see if the binding affinities measured by tryptophan fluorescence can be correlated to SPR binding affinities; if so, perhaps the tryptophan fluorescence assay will be a viable screening assay. Nonetheless, for USP5 I have already developed a <sup>19</sup>F NMR spectroscopy assay for qualitative screening and SPR for quantitative validation, which seems to be working well.</p>
<p>For those familiar with designing fluorescence based assays and accounting for IFE’s please feel free to contact me if you have suggestions/advice on my development of a tryptophan fluorescence assay for USP5 Zf-UBD.</p>
<p>References</p>
<p>Epps, D., Raub, T., Caiolfa, V., Chiar<span style="font-size: 1.5rem;">i, A., &amp; Zamai, M. </span><em style="font-size: 1.5rem;">Determination of the Affinity of Drugs toward Serum Albumin by Measurement of the Quenching of the Intrinsic Tryptophan Fluorescence of the Protein</em><span style="font-size: 1.5rem;">. J. Pharm. Pharmacol, 1999.</span><strong style="font-size: 1.5rem;"> 51</strong><span style="font-size: 1.5rem;">: 41-48.</span></p>
<p>Fonin, A., Sulatskaya, A., Kuznetsova, I., Turoveroc, K. <em>Fluorescence of Dyes in Solution with High Absorbance Inner Filter Effect Correction</em>. PLoS ONE, 2014: <strong>9</strong>(7).</p>
<p>Wang, T., Zeng, L., &amp; Li, D. <em>A review on the methods for correcting the fluorescence inner-filter effect of fluorescence spectrum. </em>Applied Spectroscopy Reviews, 2017: <strong>52</strong> (10).</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/developing-a-tryptophan-fluorescence-assay-for-screening-ligands-against-usp5-zf-ubd/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Screening Compounds against USP5 Zf-UBD with a 19F NMR assay #2</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/screening-compounds-against-usp5-zf-ubd-with-a-19f-nmr-assay-2/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/screening-compounds-against-usp5-zf-ubd-with-a-19f-nmr-assay-2/#respond</comments>
		<pubDate>Tue, 11 Sep 2018 16:07:37 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=1846</guid>
		<description><![CDATA[I used a medium-throughput 19F NMR assay to screen my second batch of compounds against USP5 zinc finger ubiquitin binding domain (Zf-UBD). To recap, the 19F NMR assay detects ligand binding by measuring perturbations in the resonance of a fluorinated tryptophan at the binding pocket. I selected the compounds for my second screen from SGC’s in <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/screening-compounds-against-usp5-zf-ubd-with-a-19f-nmr-assay-2/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>I used a medium-throughput <a href="https://thesgc.github.io/static-openlabnotebooks/compounds-of-interest-identified-by-screening-a-focused-library-against-usp5-zf-ubd-with-a-19f-nmr-assay/"><sup>19</sup>F NMR</a> assay to screen my second batch of compounds against USP5 zinc finger ubiquitin binding domain (Zf-UBD). To recap, the <sup>19</sup>F NMR assay detects ligand binding by measuring perturbations in the resonance of a fluorinated tryptophan at the binding pocket. I selected the compounds for my second screen from SGC’s in house database, based on the structure of <a href="https://thesgc.github.io/static-openlabnotebooks/co-crystal-structures-of-usp5-zf-ubd-and-weak-binding-compounds/">previous hit compounds</a>; specifically, compounds that contained an aromatic ring and a propanoate moiety. You can find details of the NMR screening results on <a href="https://zenodo.org/record/1412816#.W5e4akZKjIU">Zenodo</a>.</p>
<p>As seen previously, control fluorinated USP5 Zf-UBD spectra has two peaks of equal intensity at approximately 118 and 125 ppm. Upon ligand binding, peak 1, corresponding to the tryptophan lining the ubiquitin binding pocket, undergoes a chemical shift to the right and a decrease in peak area (Figure 1). From the 28 compounds screened, 16 showed a significant decrease in peak area and chemical shift of peak 1.  Once again, the high hit rate can be attributed to the high compound concentrated used (1 mM) in the <sup>19</sup>F NMR assay. As this assay is more qualitative than quantitative, next I will be using a SPR assay to determine the binding affinity of the hits from the <sup>19</sup>F NMR screen. I will also see if I can decrease compound concentration in future <sup>19</sup>F NMR screens.</p>
<p><img class="size-medium wp-image-1847 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180911-300x208.png" alt="" width="300" height="208" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180911-300x208.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/09/20180911.png 549w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. <sup>19</sup>F NMR spectra of 40 µM USP5<sup>171-290 </sup>without (blue) <sup> </sup>and with (red) 1 mM UBXML78</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/screening-compounds-against-usp5-zf-ubd-with-a-19f-nmr-assay-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Co-crystal structures of USP5 Zf-UBD and weak binding compounds</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/co-crystal-structures-of-usp5-zf-ubd-and-weak-binding-compounds/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/co-crystal-structures-of-usp5-zf-ubd-and-weak-binding-compounds/#comments</comments>
		<pubDate>Tue, 17 Jul 2018 16:03:28 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=1512</guid>
		<description><![CDATA[Based on previous 19F NMR and SPR assay experiments, 4 compounds were used to set up co-crystallization experiments (Table 1). I was able to get co-crystal structures of 3 of the 4 compounds! You can see full experimental details on Zenodo. Table 1. USP5 Zf-UBD ligands &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/co-crystal-structures-of-usp5-zf-ubd-and-weak-binding-compounds/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Based on previous <a href="https://thesgc.github.io/static-openlabnotebooks/compounds-of-interest-identified-by-screening-a-focused-library-against-usp5-zf-ubd-with-a-19f-nmr-assay/">19F NMR</a> and <a href="https://thesgc.github.io/static-openlabnotebooks/screening-compounds-of-interest-against-usp5-zf-ubd-with-a-surface-plasmon-resonance-assay/">SPR</a> assay experiments, 4 compounds were used to set up co-crystallization experiments (Table 1). I was able to get co-crystal structures of 3 of the 4 compounds! You can see full experimental details on <a href="https://zenodo.org/record/1313723#.W04PkdJKjIU">Zenodo</a>.</p>
<p><strong>Table 1.</strong> USP5 Zf-UBD ligands</p>
<p><img class=" wp-image-1515 alignleft" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717a-236x300.png" alt="" width="291" height="369" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717a-236x300.png 236w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717a.png 350w" sizes="(max-width: 291px) 100vw, 291px" /></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>All the compounds occupied the ubiquitin binding pocket, which is in agreement with the 19F NMR data. The electron density of the compounds were quite clear in the binding pocket of USP5 Zf-UBD. An omit map of DAT180 is shown in Figure 1.</p>
<p><img class=" wp-image-1516 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717b-300x205.png" alt="" width="342" height="234" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717b-300x205.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717b.png 624w" sizes="(max-width: 342px) 100vw, 342px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. Omit map (σ2) of USP5<sup>171-290 </sup>and DAT180</p>
<p>It is to be noted that DAT180 and DAT201 structures are now refined, were deposited in the PDB (6DXT, 6DXH) and will be available from there soon.  Table 2 summarizes the solved co-crystal structures for each compound.</p>
<p><strong>Table 2</strong>. Summary of co-crystal structures</p>
<p><img class="alignnone wp-image-1517" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717c-300x111.png" alt="" width="555" height="205" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717c-300x111.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717c.png 646w" sizes="(max-width: 555px) 100vw, 555px" /></p>
<p>Interestingly, a loop in the vicinity of DAT201 adopted a conformation not seen in previous structures of USP5 (Figure 2). The novel cavity resulting from this conformational shift may be exploited for the design of follow-up compounds.</p>
<p><img class="size-medium wp-image-1520 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717e-300x229.png" alt="" width="300" height="229" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717e-300x229.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717e.png 514w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. Overlay of DAT201 structure (yellow) &amp; PDB: <a href="https://www.rcsb.org/structure/2G43">2G43</a> (purple)</p>
<p>The solved crystal structure of DAT194 was the most interesting of the solved structures. We saw electron density in the binding pocket but it did not correlate with the structure of the compound we had ordered! After some discussion, we tried to see if modeling an isomer of that compound would “fit” and it fit beautifully (Figure 3b). Both DAT194 and the Figure 3b isomer have the same mass. The purity of DAT194 was &gt;95% when checked by UPLC/MS. It’s very cool to see that the high resolution crystal structure can differentiate between isomers.</p>
<p><img class="alignnone wp-image-1518 aligncenter" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717d-300x126.png" alt="" width="338" height="142" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717d-300x126.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/07/20180717d.png 386w" sizes="(max-width: 338px) 100vw, 338px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. a) Expected DAT194 structure b) Modeled isomer with same mass as DAT194</p>
<p>In the future, I’ll be using computational techniques to prioritize chemical analogs that may better exploit the binding pocket. Decorating the core scaffold of the compounds with different chemical groups can potentially increase ligand affinity to the protein domain. Stay tuned!</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/co-crystal-structures-of-usp5-zf-ubd-and-weak-binding-compounds/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
	</channel>
</rss>
